Zhenguo Zi

606 total citations
10 papers, 454 citations indexed

About

Zhenguo Zi is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Zhenguo Zi has authored 10 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Zhenguo Zi's work include Autophagy in Disease and Therapy (3 papers), CAR-T cell therapy research (3 papers) and Nanowire Synthesis and Applications (2 papers). Zhenguo Zi is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), CAR-T cell therapy research (3 papers) and Nanowire Synthesis and Applications (2 papers). Zhenguo Zi collaborates with scholars based in China, North Korea and South Korea. Zhenguo Zi's co-authors include Fang Wei, Qiliang Cai, Xiaojing Ma, Kang Shao, Yanling Jin, Wenjin Zhang, Yong Yang, Yaping Jiang, Jianqiang Yu and Guangjiang Shi and has published in prestigious journals such as Scientific Reports, Cell Reports and Journal of Cellular Physiology.

In The Last Decade

Zhenguo Zi

10 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenguo Zi China 7 225 180 107 76 61 10 454
Wenjing Luo China 12 216 1.0× 206 1.1× 153 1.4× 84 1.1× 55 0.9× 69 683
Guangjun Jing China 13 244 1.1× 257 1.4× 112 1.0× 72 0.9× 61 1.0× 22 643
Sijie Wang China 11 269 1.2× 149 0.8× 129 1.2× 79 1.0× 109 1.8× 20 487
Juliang Qin China 14 181 0.8× 236 1.3× 241 2.3× 26 0.3× 37 0.6× 22 597
Yuichiro Higuchi Japan 15 92 0.4× 332 1.8× 108 1.0× 123 1.6× 63 1.0× 45 694
Feng Tang China 16 88 0.4× 205 1.1× 34 0.3× 49 0.6× 17 0.3× 51 483
Maud Voisin United States 8 59 0.3× 190 1.1× 144 1.3× 46 0.6× 11 0.2× 12 413
Katharina John Germany 13 99 0.4× 182 1.0× 89 0.8× 38 0.5× 14 0.2× 20 533
Karen A. Squillace United States 7 54 0.2× 248 1.4× 90 0.8× 65 0.9× 24 0.4× 8 469
Rocío Navarro Spain 10 128 0.6× 136 0.8× 116 1.1× 18 0.2× 31 0.5× 20 394

Countries citing papers authored by Zhenguo Zi

Since Specialization
Citations

This map shows the geographic impact of Zhenguo Zi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenguo Zi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenguo Zi more than expected).

Fields of papers citing papers by Zhenguo Zi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenguo Zi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenguo Zi. The network helps show where Zhenguo Zi may publish in the future.

Co-authorship network of co-authors of Zhenguo Zi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenguo Zi. A scholar is included among the top collaborators of Zhenguo Zi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenguo Zi. Zhenguo Zi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Zi, Zhenguo, Shujuan Du, Liming Zhang, et al.. (2023). Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability. Blood Advances. 7(15). 4049–4063. 5 indexed citations
2.
Sun, Ke, et al.. (2023). Ligand-based adoptive T cell targeting CA125 in ovarian cancer. Journal of Translational Medicine. 21(1). 596–596. 6 indexed citations
3.
Zhang, Shasha, Lin An, Zhenguo Zi, et al.. (2021). Muscle-specific programmed cell death 5 deletion attenuates cardiac aging. International Journal of Cardiology. 345. 98–104. 4 indexed citations
4.
5.
Yang, Xiangyu, et al.. (2019). Circ_0005075 promotes hepatocellular carcinoma progression by suppression of microRNA‐335. Journal of Cellular Physiology. 234(12). 21937–21946. 19 indexed citations
6.
Zhu, Qing, Ling Ding, Zhenguo Zi, et al.. (2019). Viral-Mediated AURKB Cleavage Promotes Cell Segregation and Tumorigenesis. Cell Reports. 26(13). 3657–3671.e5. 30 indexed citations
7.
Zi, Zhenguo, Yanling Jin, Kang Shao, et al.. (2018). CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions. Cancer Immunology Immunotherapy. 68(3). 365–377. 217 indexed citations
8.
Shi, Guangjiang, Wenjin Zhang, Yaping Jiang, et al.. (2018). Involvement of growth factors in diabetes mellitus and its complications: A general review. Biomedicine & Pharmacotherapy. 101. 510–527. 105 indexed citations
9.
An, Lin, Xiaowen Hu, Shasha Zhang, et al.. (2017). UVRAG Deficiency Exacerbates Doxorubicin-Induced Cardiotoxicity. Scientific Reports. 7(1). 43251–43251. 30 indexed citations
10.
Zi, Zhenguo, Shasha Zhang, Yong Ye, et al.. (2014). Rubicon Deficiency Enhances Cardiac Autophagy and Protects Mice From Lipopolysaccharide-induced Lethality and Reduction in Stroke Volume. Journal of Cardiovascular Pharmacology. 65(3). 252–261. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026